Olympus Corporation

2026/01/16 Updated
Market Cap: $14.4B (¥2.3T)
Stock Price: $13.08 (¥2,073)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
24.04
PER (Price Earnings Ratio)
vs Industry Avg: +14.5
3.13
PBR (Price to Book Ratio)
vs Industry Avg: +1.9
1.45%
Dividend Yield
vs Industry Avg: -1.50%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
-0.63%
Near-term
25-Day MA
+2.04%
Mid-term
75-Day MA
+4.73%
Long-term
200-Day MA
+10.29%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥2,113
Open ¥2,098
High ¥2,110
Low ¥2,064
Close ¥2,073

TRADING

Volume 3,420,100
Average Volume 3,227,637
Turnover ¥71億
Min. Purchase ¥207,300

Analyst Recommendations 14 analysts

Updated 2026/01/11
Strong Buy
2
2
Buy
3
3
Hold
8
8
Sell
0
Strong Sell
1
1
Target Price (Mean)
¥2,070
None
¥2,700
High
¥2,000
Median
¥1,750
Low
+4% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11
4.3%
Insider Holdings
60.0%
Institutional
35.7%
Public Float
322
Institutional Holders
Insider Holdings 4.3%
Institutional 60.0%
Public Float 35.7%

Top Mutual Funds / ETFs

Updated 2026/01/11

Major Holders

Updated 2026/01/11
Fund Name Ownership Shares Change
Dodge & Cox Funds-Dodge & Cox International Stock Fund
1.92%
21.4M 0.00%
MFS Series Trust XVII-MFS International Equity Fund
1.83%
20.4M +25.49%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.41%
15.7M +0.05%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.90%
10.0M +2.40%
Bridge Builder Trust-Bridge Builder International Equity Fund
0.70%
7.7M -27.13%
iShares Trust-iShares Core MSCI EAFE ETF
0.70%
7.8M +0.84%
Institution Ownership Shares Change
Pacer Advisors, Inc.
<0.01%
11.8K +0.72%

Dividend History 4Years Growth

Updated 2026/01/11
-%
Dividend Yield
¥20
Annual Dividend
+11.1%
YoY Growth
19.5%
Payout Ratio
Year Dividend Change
2025 ¥20 +11.1%
2024 ¥18 +12.5%
2023 ¥16 +14.3%
2022 ¥14 +16.7%
2021 ¥12 -

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥750,123M ¥881,923M ¥925,752M ¥997,332M
Gross Profit ¥506,700M ¥596,849M ¥618,432M ¥683,697M
Operating Income ¥144,696M ¥186,118M ¥51,745M ¥161,996M
Pretax Income ¥147,539M ¥190,469M ¥53,907M ¥165,911M
Net Income ¥115,742M ¥143,432M ¥242,566M ¥117,855M
EPS ¥90.17 ¥113.08 ¥199.44 ¥102.80
Operating Margin 19.29% 21.10% 5.59% 16.24%
Balance Sheet
Total Assets ¥1,357,999M ¥1,508,701M ¥1,534,216M ¥1,432,826M
Total Equity ¥510,168M ¥640,085M ¥757,186M ¥751,733M
Total Liabilities ¥847,831M ¥868,616M ¥777,030M ¥681,093M
Cash ¥302,572M ¥169,329M ¥340,933M ¥252,532M
Interest-bearing Debt ¥386,127M ¥340,057M ¥299,616M ¥229,102M
Equity Ratio 37.57% 42.43% 49.35% 52.47%
D/E Ratio 0.76 0.53 0.40 0.30
Cash Flow
Operating CF ¥169,729M ¥98,490M ¥42,365M ¥190,463M
Investing CF -¥71,016M -¥58,414M ¥359,992M -¥65,469M
Financing CF -¥40,667M -¥143,178M -¥276,010M -¥211,542M
Free CF ¥107,958M ¥27,867M -¥22,259M ¥125,254M
Efficiency
ROE 22.69% 22.41% 32.04% 15.68%
ROA 8.52% 9.51% 15.81% 8.23%

Company Information

English Name Olympus Corporation
Japanese Name オリンパス(株)
Stock Code 7733.T (JPX)
Sector / Industry Healthcare / Medical Devices
Employees 29,297

About

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Data provided by Yahoo Finance